Asheville, North Carolina: The Origin of the American Tuberculosis Sanitarium Movement
View abstract on PubMed
Summary
This summary is machine-generated.Dr. Gleitsmann established the first US tuberculosis sanitarium in Asheville in 1875, pioneering climatotherapy. Asheville became a major tuberculosis treatment center, driving medical tourism and research before antibiotics.
Area Of Science
- Medical History
- Pulmonology
- Public Health
Background
- Digitized 1800s publications identify Dr. Joseph W. Gleitsmann as the founder of the first US tuberculosis sanitarium in Asheville, NC, in 1875.
- This facility predated the Trudeau Sanatorium by nine years and utilized German climatological methods and a structured treatment program.
Purpose Of The Study
- To highlight Asheville's pivotal role in the development of climatotherapy for tuberculosis treatment in the pre-antibiotic era.
- To document the historical significance of early tuberculosis sanitaria and related medical research in Asheville.
Main Methods
- Analysis of digitized academic publications and newspapers from the 1800s.
- Review of historical data on Asheville's population growth and medical tourism.
- Examination of research output from the Von Ruck Research Laboratory for Tuberculosis.
Main Results
- Gleitsmann's Mountain Sanitarium operated with 30 beds and published outcomes by 1880.
- By 1910, Asheville hosted 25 private sanitaria, becoming a national tuberculosis care hub.
- The Von Ruck Laboratory produced over 50 papers on immunotherapy and Mycobacterium tuberculosis.
- Medical tourism significantly fueled Asheville's population growth from 1870 to 1930.
Conclusions
- Asheville was a key center for climatotherapy and tuberculosis research before antibiotics.
- Despite early research, tuberculosis stigmatization led to the demolition of sanitaria.
- Historical acceptance of partially effective treatments parallels modern acceptance of immunotherapies and vaccines.
Related Concept Videos
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
• Class zero: The individual has no known TB exposure and has a negative tuberculin skin test.
• Class one: The individual has been exposed to...
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

